Genetic testing

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Genotype Guided Antiplatelet Therapy In Ischemic Stroke

Cancer Genetic Testing in Ethnic Populations

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Strategic Targeting for Optimal Prevention of Cancer

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Early Onset Alzheimer's Disease Genomic Study

Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)

Telecommunication Technology-based Online Survey

Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer